Fifteen Minute Test May Save 15% or More on Rosacea Treatment

Evan Darwin, Jessica Cervantes, Hadar Lev-Tov

Research output: Contribution to journalArticlepeer-review

Abstract

Rosacea is a common inflammatory skin condition that impacts a large portion of fair-skinned populations. The redness associated with rosacea can be a significant challenge. Brimonidine sulfate and oxymetazoline HCL were both recently approved by the FDA for the management of facial redness. These agents, however, are costly, and not all patients respond to the medication. Herein, we describe a clinical pearl that helps to optimize patient selection for the medications. This saves the patient and the health care system both time and money. J Drugs Dermatol. 2018;17(5):692-693.

Original languageEnglish (US)
Pages (from-to)692-693
Number of pages2
JournalJournal of drugs in dermatology : JDD
Volume17
Issue number6
StatePublished - Jun 1 2018
Externally publishedYes

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'Fifteen Minute Test May Save 15% or More on Rosacea Treatment'. Together they form a unique fingerprint.

Cite this